HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William Rojas-Carabali Selected Research

Uveitis

5/2024Clinical Insights: Antimicrobial Therapy for Infectious Uveitis.
2/2024Uveitis and Dry Eye Disease in Children: A Cross-Sectional Comparative Study.
11/2023Multiple Sclerosis in a Patient with Intermediate Uveitis and Juvenile Idiopathic Arthritis Treated with Adalimumab: A Case Report.
10/2023Immunogenicity of Adalimumab in Patients with Non-Infectious- Uveitis: Systematic Review and Meta-Analysis.
9/2023Psychosocial Well-Being and Quality of Life in Uveitis: A Review.
1/2022Ocular Manifestations Related to Antibodies Positivity and Inflammatory Biomarkers in a Rheumatological Cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William Rojas-Carabali Research Topics

Disease

6Uveitis
05/2024 - 01/2022
2Glaucoma
02/2024 - 09/2022
2Ocular Hypertension (Glaucoma, Suspect)
02/2024 - 01/2024
2Acute Retinal Necrosis Syndrome
01/2024 - 10/2021
2Autoimmune Diseases (Autoimmune Disease)
12/2023 - 12/2022
2Multiple Sclerosis
11/2023 - 10/2021
2Conjunctivitis
08/2023 - 01/2022
1Blindness (Hysterical Blindness)
02/2024
1Neurodegenerative Diseases (Neurodegenerative Disease)
02/2024
1Ganglion Cysts (Ganglion)
02/2024
1Hypertension (High Blood Pressure)
01/2024
1Optic Nerve Diseases (Optic Neuropathy)
01/2024
1Paresthesia (Dysesthesia)
11/2023
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
11/2023
1Intermediate Uveitis (Chronic Cyclitis)
11/2023
1Infections
03/2023
1Relapsing Polychondritis
01/2023
1Retinal Artery Occlusion
10/2022
1Scleritis (Episcleritis)
10/2022
1Amaurosis Fugax
10/2022
1Macular Degeneration (Age-Related Maculopathy)
01/2022
1Photophobia (Light Sensitivity)
01/2022
1Retinal Vasculitis
01/2022
1Graves Ophthalmopathy
10/2021
1Macular Edema
10/2021
1Corneal Edema
10/2021
1Anaphylaxis (Anaphylactic Shock)
01/2021

Drug/Important Bio-Agent (IBA)

3Adalimumab (Humira)FDA Link
11/2023 - 09/2022
2Retinaldehyde (Retinal)IBA
02/2024 - 10/2022
2hydroxide ionIBA
02/2024 - 01/2024
2Antiviral Agents (Antivirals)IBA
01/2024 - 08/2023
2AntibodiesIBA
10/2023 - 01/2022
2SteroidsIBA
12/2022 - 10/2021
1LipidsIBA
02/2024
1CytokinesIBA
01/2024
1GlucocorticoidsIBA
01/2024
1Vitamin DFDA LinkGeneric
12/2023
1Biological FactorsIBA
09/2023
1tecovirimatIBA
08/2023
1Clindamycin (Cleocin)FDA LinkGeneric
03/2023
1Proteoglycans (Proteoglycan)IBA
01/2023
1Prothrombin (Factor II)IBA
10/2022
1Methotrexate (Mexate)FDA LinkGeneric
09/2022
1Complement C3 (C3 Complement)IBA
01/2022
1Anti-Citrullinated Protein AntibodiesIBA
01/2022
1siponimodIBA
10/2021
1Amantadine (Aman)FDA LinkGeneric
10/2021
1InterferonsIBA
10/2021
1Alemtuzumab (Campath)FDA Link
10/2021
1Fingolimod Hydrochloride (FTY720)FDA Link
10/2021
1Immunoglobulin E (IgE)IBA
01/2021

Therapy/Procedure

4Therapeutics
05/2024 - 10/2021
2Immunomodulation
12/2023 - 09/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
02/2024
1Intravitreal Injections
01/2024
1Vitrectomy
03/2023